Dr. Reddy’s denies workforce cost reduction exercise 


Pharma major Dr. Reddy’s Laboratories has denied it has embarked on an exercise aimed at a 25% workforce cost reduction.

The company on Monday evening dismissed a media report which, citing sources, said the Hyderabad-headquartered generic drugmaker, as part of a 25% workforce cost cutting exercise, had asked several employees drawing relatively high salaries, especially many of those earning over ₹1 crore annually, to resign.

“We categorically deny the claim of a 25% workforce cost reduction and the other claims mentioned,” Dr. Reddy’s said in a filing with the stock exchanges. The company does not comment on market speculations and there is currently no such event or information which requires a disclosure, it said.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *